Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Clinical Research
  • Published:

Dietary inflammatory index and prostate cancer risk: MCC-Spain study

Abstract

Background

The etiology of prostate cancer (PCa) is not well-known, and the role of diet is not well established. We aimed to evaluate the role of the inflammatory power of the diet, measured by the Dietary Inflammatory Index (DII®), on the risk of PCa.

Methodology

A population-based multicase-control (MCC-Spain) study was conducted. Information was collected on sociodemographic characteristics, personal and family antecedents, and lifestyles, including diet from a Food Frequency Questionnaire. The inflammatory potential of the diet was assessed using the energy-adjusted Dietary Inflammatory Index (E-DII) based on 30 parameters (a higher score indicates a higher inflammatory capacity of the diet). Tertiles of E-DII were created using the cut-off points from the control group. The International Society of Urology Pathology (ISUP) was grouped as ISUP 1, ISUP 2, or ISUP 3–5. Unconditional logistic regression models were used to estimate adjusted odds ratios (aOR) and 95% confidence intervals (CI) for the association between E-DII score and PCa risk.

Results

A total of 928 PCa cases and 1278 population controls were included. Among PCa cases, the mean value of the E-DII score was 0.18 (SD: 1.9) vs. 0.07 (SD: 1.9) in the control group (p = 0.162). Cases with a more pro-inflammatory diet (3rd tertile) had the highest risk of PCa, aORT3vsT1 = 1.30 (95% CI 1.03–1.65) (p-trend = 0.026). When stratifying by ISUP, this risk association was observed only for ISUP 2 and ISUP 3–5, aORT3vsT1 = 1.46 (95% CI 1.02–2.10) and 1.60 (95% CI 1.10–2.34), respectively.

Conclusion

A positive association was observed between consuming a pro-inflammatory diet and PCa in the MCC-Spain population, specifically for an ISUP grade greater or equal than 2.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1

Similar content being viewed by others

Data availability

The data that are used in this study are available from the corresponding authors upon reasonable request.

References

  1. Dyba T, Randi G, Bray F, Martos C, Giusti F, Nicholson N, et al. The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers. Eur J Cancer. 2021;157:308–47.

    Article  Google Scholar 

  2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a Cancer J Clinicians. 2021;71:209–49.

    Google Scholar 

  3. Rawla P. Epidemiology of Prostate Cancer. World J Oncol. 2019;10:63–89.

    Article  CAS  Google Scholar 

  4. Gutiérrez-González E, Castello A, Fernandez-Navarro P, Castaño-Vinyals G, Llorca J, Salas D et al. Dietary Zinc and Risk of Prostate Cancer in Spain: MCC-Spain Study. Nutrients. 2018;11:18.

    Article  Google Scholar 

  5. Steck SE, Omofuma OO, Su LJ, Maise AA, Woloszynska-Read A, Johnson CS, et al. Calcium, magnesium, and whole-milk intakes and high-aggressive prostate cancer in the North Carolina-Louisiana Prostate Cancer Project (PCaP). Am J Clin Nutr. 2018;107:799–807.

    Article  Google Scholar 

  6. Rahmati S, Azami M, Delpisheh A, Hafezi Ahmadi MR, Sayehmiri K. Total Calcium (Dietary and Supplementary) Intake and Prostate Cancer: a Systematic Review and Meta-Analysis. Asian Pac J Cancer Prev: APJCP. 2018;19:1449–56.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Chazelas E, Srour B, Desmetz E, Kesse-Guyot E, Julia C, Deschamps V et al. Sugary drink consumption and risk of cancer: Results from NutriNet-Santé prospective cohort. The BMJ. 2019;366:l2408.

  8. Perez-Cornago A, Travis RC, Appleby PN, Tsilidis KK, Tjonneland A, Olsen A, et al. Fruit and vegetable intake and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer. 2017;141:287–97.

    Article  CAS  Google Scholar 

  9. Knuppel A, Papier K, Fensom GK, Appleby PN, Schmidt JA, Tong TYN, et al. Meat intake and cancer risk: prospective analyses in UK Biobank. Int J Epidemiol. 2020;49:1540–52.

    Article  Google Scholar 

  10. Hong S, Khil H, Lee DH, Keum N, Giovannucci EL. Alcohol Consumption and the Risk of Prostate Cancer: A Dose-Response Meta-Analysis. Nutrients. 2020;12:1–17.

    Google Scholar 

  11. Castello A, Boldo E, Amiano P, Castano-Vinyals G, Aragones N, Gomez-Acebo I, et al. Mediterranean Dietary Pattern is Associated with Low Risk of Aggressive Prostate Cancer: MCC-Spain Study. J Urol. 2018;199:430–7.

    Article  Google Scholar 

  12. Trudeau K, Rousseau M-C, Barul C, Csizmadi I, Parent M-É. Dietary Patterns Are Associated with Risk of Prostate Cancer in a Population-Based Case-Control Study in Montreal, Canada. Nutrients. 2020;12:1907.

    Article  Google Scholar 

  13. Lin P-H, Aronson W, Freedland SJ. An update of research evidence on nutrition and prostate cancer. Urologic Oncol. 2019;37:387–401.

    Article  CAS  Google Scholar 

  14. Agents Classified by the IARC Monographs, Volumes 1–125 – IARC Monographs on the Identification of Carcinogenic Hazards to Humans. https://monographs.iarc.fr/agents-classified-by-the-iarc/ (accessed 2 Apr 2020).

  15. World Cancer Research Fund International. Diet, nutrition, physical activity and prostate cancer. World cancer research fund international 2014;50.

  16. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association. Circulation. 2003;107:499–511.

    Article  Google Scholar 

  17. Van’t Klooster CC, Ridker PM, Hjortnaes J, van der Graaf Y, Asselbergs FW, Westerink J, et al. The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease: a cohort study. Eur Heart J. 2019;40:3901–9.

    Article  Google Scholar 

  18. Cai T, Santi R, Tamanini I, Galli IC, Perletti G, Bjerklund Johansen TE et al. Current Knowledge of the Potential Links between Inflammation and Prostate Cancer. Int. J Mol Sci. 2019;20:3833.

  19. Shivappa N, Hebert JR, Rosato V, Rossi M, Libra M, Montella M, et al. Dietary Inflammatory Index and Risk of Bladder Cancer in a Large Italian Case-control Study. Urology. 2017;100:84–89.

    Article  Google Scholar 

  20. Fowler ME, Akinyemiju TF. Meta-analysis of the association between dietary inflammatory index (DII) and cancer outcomes. Int J Cancer. 2017;141:2215–27.

    Article  CAS  Google Scholar 

  21. Abulimiti A, Zhang X, Shivappa N, Hébert JR, Fang Y-J, Huang C-Y et al. The Dietary Inflammatory Index Is Positively Associated with Colorectal Cancer Risk in a Chinese Case-Control Study. Nutrients. 2020;12:10232.

  22. Obon-Santacana M, Romaguera D, Gracia-Lavedan E, Molinuevo A, Molina-Montes E, Shivappa N et al. Dietary Inflammatory Index, Dietary Non-Enzymatic Antioxidant Capacity, and Colorectal and Breast Cancer Risk (MCC-Spain Study). Nutrients. 2019;11:1406.

  23. Liu F-H, Liu C, Gong T-T, Gao S, Sun H, Jiang Y-T, et al. Dietary Inflammatory Index and Health Outcomes: An Umbrella Review of Systematic Review and Meta-Analyses of Observational Studies. Front Nutr. 2021;8:190.

    Google Scholar 

  24. Graffouillere L, Deschasaux M, Mariotti F, Neufcourt L, Shivappa N, Hebert JR, et al. The Dietary Inflammatory Index Is Associated with Prostate Cancer Risk in French Middle-Aged Adults in a Prospective Study. J Nutr. 2016;146:785–91.

    Article  CAS  Google Scholar 

  25. Shivappa N, Bosetti C, Zucchetto A, Montella M, Serraino D, La Vecchia C, et al. Association between dietary inflammatory index and prostate cancer among Italian men. Br J Nutr. 2015;113:278–83.

    Article  CAS  Google Scholar 

  26. Castano-Vinyals G, Aragones N, Perez-Gomez B, Martin V, Llorca J, Moreno V, et al. Population-based multicase-control study in common tumors in Spain (MCC-Spain): rationale and study design. Gac Sanit. 2015;29:308–15.

    Article  Google Scholar 

  27. Versión ICD-10: 2016. https://icd.who.int/browse10/2016/en (accessed 20 Jan 2020).

  28. Willett W. Nutritional Epidemiology. Oxford University Press, 2013 https://doi.org/10.1093/acprof:oso/9780199754038.001.0001.

  29. Garcia-Closas R, Garcia-Closas M, Kogevinas M, Malats N, Silverman D, Serra C, et al. Food, nutrient and heterocyclic amine intake and the risk of bladder cancer. Eur J Cancer (Oxf, Engl: 1990). 2007;43:1731–40.

    Article  CAS  Google Scholar 

  30. Tablas de composición de alimentos del CESNID. http://www.sennutricion.org/es/2013/05/13/tablas-de-composicin-de-alimentos-del-cesnid (accessed 7 Nov2019).

  31. Hebert JR, Shivappa N, Wirth MD, Hussey JR, Hurley TG. Perspective: The Dietary Inflammatory Index (DII®): Lessons Learned, Improvements Made and Future Directions. Adv Nutr 2019;10:185–95.

    Article  Google Scholar 

  32. Flores JC, Gracia-Lavedan E, Benavente Y, Amiano P, Romaguera D, Costas L, et al. The dietary inflammatory index and chronic lymphocytic leukaemia in the MCC Spain study. Nutrients. 2020;12:1–15.

    Google Scholar 

  33. Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA, et al. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surgical Pathol. 2015;40:244–52.

    Article  Google Scholar 

  34. Sfanos KS, de Marzo AM. Prostate cancer and inflammation: The evidence. Histopathology. 2012;60:199–215.

    Article  Google Scholar 

  35. Hoang DVan, Shivappa N, Pham NM, Hebert JR, Binns CW, Lee AH. Dietary inflammatory index is associated with increased risk for prostate cancer among Vietnamese men. Nutrition. 2019;62:140–5.

    Article  Google Scholar 

  36. Shivappa N, Niclis C, Coquet JB, Román MD, Hébert JR, Diaz M, et al. Increased inflammatory potential of diet is associated with increased odds of prostate cancer in Argentinian men. Cancer Causes Control. 2018;29:803–13.

    Article  Google Scholar 

  37. Shivappa N, Miao Q, Walker M, Hébert JR, Aronson KJ. Association Between a Dietary Inflammatory Index and Prostate Cancer Risk in Ontario, Canada. Nutr Cancer. 2017;69:825–32.

    Article  Google Scholar 

  38. Shivappa N, Hébert JR, Askari F, Kardoust Parizi M, Rashidkhani B. Increased Inflammatory Potential of Diet is Associated with Increased Risk of Prostate Cancer in Iranian Men. Int J Vitam Nutr Res Int Z fur Vitam- und Ernahrungsforschung J Int de vitaminologie et de Nutr. 2016;86:161–8.

    Article  CAS  Google Scholar 

  39. Shivappa N, Jalilpiran Y JRH, Faghih S. Association between Dietary Inflammatory Index and Prostate Cancer in Shiraz Province of Iran. Asian Pac J Cancer Prev. 2018;19:415–20.

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Shivappa N, Jackson MD, Bennett F, Hebert JR. Increased Dietary Inflammatory Index (DII) Is Associated With Increased Risk of Prostate Cancer in Jamaican Men. Nutr Cancer. 2015;67:941–8.

    Article  CAS  Google Scholar 

  41. Vidal AC, Oyekunle T, Howard LE, Shivappa N, de Hoedt A, Figueiredo JC, et al. Dietary inflammatory index (DII) and risk of prostate cancer in a case-control study among Black and White US Veteran men. Prostate Cancer Prostatic Dis. 2019;22:580–7.

    Article  Google Scholar 

  42. McMahon DM, Burch JB, Hébert JR, Hardin JW, Zhang J, Wirth MD, et al. Diet-related inflammation and risk of prostate cancer in the California Men’s Health Study. Ann Epidemiol. 2019;29:30–38.

    Article  Google Scholar 

  43. Vázquez-Salas RA, Shivappa N, Galván-Portillo M, López-Carrillo L, Hébert JR, Torres-Sánchez L. Dietary inflammatory index and prostate cancer risk in a case-control study in Mexico. Br J Nutr. 2016;116:1945–53.

    Article  Google Scholar 

  44. Koloverou E, Panagiotakos DB, Pitsavos C, Chrysohoou C, Georgousopoulou EN, Grekas A, et al. Adherence to Mediterranean diet and 10-year incidence (2002-2012) of diabetes: correlations with inflammatory and oxidative stress biomarkers in the ATTICA cohort study. Diabetes/Metab Res Rev. 2016;32:73–81.

    Article  CAS  Google Scholar 

  45. Gueron G, De Siervi A, Vazquez E. Advanced prostate cancer: Reinforcing the strings between inflammation and the metastatic behavior. Prostate Cancer Prostatic Dis. 2012;15:213–21.

    Article  CAS  Google Scholar 

  46. Shivappa N, Hebert JR, Rietzschel ER, De Buyzere ML, Langlois M, Debruyne E, et al. Associations between dietary inflammatory index and inflammatory markers in the Asklepios Study. Br J Nutr. 2015;113:665–71.

    Article  CAS  Google Scholar 

  47. Shivappa N, Hebert JR, Marcos A, Diaz L-E, Gomez S, Nova E et al. Association between dietary inflammatory index and inflammatory markers in the HELENA study. Mol. Nutr. Food Res. 2017;61. https://doi.org/10.1002/mnfr.201600707.

  48. Luo J, Shivappa N, Hébert JR, Xu X. Dietary inflammatory index and bladder cancer risk: a prospective study. Eur J Clin Nutr. 2020. https://doi.org/10.1038/s41430-020-0602-y.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Jensen OM, Wahrendorf J, Rosenqvist A, Geser A. The reliability of questionnaire-derived historical dietary information and temporal stability of food habits in individuals. Am J Epidemiol. 1984;120:281–90.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We appreciate the collaboration of all those who participated in providing questionnaire data. We thank all MCC-Spain study group members and collaborators.

Author information

Authors and Affiliations

Authors

Consortia

Contributions

GC-V, MP, MK and JJJ-M conceptualisation and design of the study; ML-L, IS-B, RO-R, GC-V, NS, JRH and JJJ-M formal analysis of data; GC-V, PA, BP-G, JA, GF-T, NA, MP, MK and JJJ-M funding acquisition; GC-V, NA, MP and MK project administration; ML-L, and JJJ-M first draft of this paper. All authors contributed to the interpretation of the results and revised the manuscript. This research was partially funded by the public grants from the Catalan Government (2014SGR756, 2017SGR1085, 2017SGR733, SLT006/17/76), and European Regional Development Fund-ERDF, by the “Acción Transversal del Cancer”, approved on the Spanish Ministry Council on the 11th October 2007, by the Instituto de Salud Carlos III-FEDER (PI08/1770, PI08/0533, PI08/1359, PS09/00773-Cantabria, PS09/01286-León, PS09/01903-Valencia, PS09/02078-Huelva, PS09/ 01662-Granada, PI11/01403, PI11/01889-FEDER, PI11/00226, PI11/01810, PI11/02213, PI12/00488, PI12/00265, PI12/01270, PI12/00715, PI12/00150, PI14/01219, PI14/0613, PI15/00069, PI15/00914, PI15/01032, PIE16/00049, PI17/01179, PI17-00092, PI17CIII/00034), by the Fundación Marqués de Valdecilla (API 10/09), by the Red Temática de Investigación del Cáncer (RTICC) del ISCIII(RD12/0036/0036), by the Junta de Castilla y León (LE22A10-2), by the Consejería de Salud of the Junta de Andalucía (PI-0571-2009, PI-0306-2011, salud201200057018tra), by the Conselleria de Sanitat of the Generalitat Valenciana (AP_061/10), by the Recercaixa (2010ACUP00310), by the Regional Government of the Basque Country, by the Consejería de Sanidad de la Región de Murcia, by the European Commission grants FOOD-CT-2006-036224-HIWATE, by the Spanish Association Against Cancer (AECC) Scientific Foundation – gran GCTRA18022MORE, by the Catalan Government-Agency for Management of University and Research Grants (AGAUR) grants 2014SGR647, 2014SGR850 and 2017SGR723. Sample collection of this work was supported by the Xarxa de Bancs de Tumors de Catalunya sponsored by Pla Director d’Oncología de Catalunya (XBTC)”, Plataforma Biobancos PT13/0010/0013” and ICOBIOBANC, sponsored by the Catalan Institute of Oncology. ISGlobal acknowledges support from the Spanish Ministry of Science and Innovation through the “Centro de Excelencia Severo Ochoa 2019-2023” Program (CEX2018-000806-S), and support from the Generalitat de Catalunya through the CERCA Program.

Corresponding authors

Correspondence to Inmaculada Salcedo-Bellido or José-Juan Jiménez-Moleón.

Ethics declarations

Competing interests

James R Hébert, own controlling interest in Connecting Health Innovations LLC, a company that has licensed the right to my invention of the DII®. Nitin Shivappa is an employee of Connecting Health Innovations LLC. The rest of authors declare that they have no conflict of interest.

Ethics approval and consent to participate

All participants who were eligible to participate in the study and agreed to participate were fully informed about the study objectives and signed an informed consent form. The study was approved by the Ethics Committee of all participating centers, in conformity to the principles of the Declaration of Helsinki.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lozano-Lorca, M., Salcedo-Bellido, I., Olmedo-Requena, R. et al. Dietary inflammatory index and prostate cancer risk: MCC-Spain study. Prostate Cancer Prostatic Dis 25, 568–575 (2022). https://doi.org/10.1038/s41391-022-00532-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41391-022-00532-7

This article is cited by

Search

Quick links